Search Results

124 results found for 'dopamine'

Article

PSC-funded researchers: Where are they now?

PSC is proud of the many researcher success stories that have resulted from our funding program. In the coming months, we will be taking a look back at those we have funded and will update you on their progress. Here is a small sample of PSC funding success stories. Dr. Oleh Hornykiewicz Professor Emeritus, University […]
Read more about PSC-funded researchers: Where are they now?

Article

Help improve access to a new Parkinson’s medication

Do you use the Parkinson’s treatment NEUPRO®? If so, we would like to hear from you. Parkinson Society Canada is looking to make a stronger case to the Canadian Agency for Drugs and Technologies in Health (CADTH) on the need for Canadians affected by Parkinson’s to have access to the new Parkinson’s treatment NEUPRO®. We […]
Read more about Help improve access to a new Parkinson’s medication

Article

What is deep brain stimulation, anyway?

Whether you’ve recently heard about deep brain stimulation (DBS) in the news, heard of it from a friend of a friend, or you’re hearing about the term for the first time right now – allow us to explain. What is DBS? Deep brain stimulation (DBS) is a surgical treatment for Parkinson’s that involves the implantation […]
Read more about What is deep brain stimulation, anyway?

Article

Putting Parkinson’s on the Map: Our first 50 Years

Since 1965, Parkinson Society Canada (PSC), together with its regional partners, has reached into cities, towns and rural areas across the country to provide education and services, to lobby governments and create a National Research Program. We have truly put Parkinson’s on the map through heightened awareness and scientific discoveries, not only in Canada, but […]
Read more about Putting Parkinson’s on the Map: Our first 50 Years

Article

LUMA trial: A setback, not a defeat

Experimental drug falls short in broad study—but research continues Biogen and Denali have shared results from the LUMA trial, a study of 648 participants aged 30 to 80 designed to test whether an experimental drug called BIIB122 (DNL151) could slow symptom progression in people with early-stage Parkinson’s. The trial’s main goal was to determine whether […]
Read more about LUMA trial: A setback, not a defeat

Article

Parkinson's OFF-time: what you need to know and how to manage it

There’s a lot to understand when it comes to Parkinson’s and OFF-time is an important part of managing one’s symptoms.   It is possible for people living with Parkinson’s to live fully and manage their motor symptoms, including tremors, impaired balance and slowness of movement, with medication such as levodopa which is specifically developed to help […]
Read more about Parkinson's OFF-time: what you need to know and how to manage it

Article

Donald Calne Lecture

Location, location, location critical in Parkinson’s disease Dr. Andres Lozano, distinguished neurosurgeon, professor and RR Tasker Chair in Functional Neurosurgery at the University of Toronto addressed over 120 attendees at the Donald Calne Lecture hosted by Parkinson Society Canada and Parkinson Society Ottawa, on Sunday, May 16th in Ottawa at the Fairmont Chateau Laurier. Dr. Lozano, who […]
Read more about Donald Calne Lecture
Back to top